{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:50:03Z","timestamp":1776390603932,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14255-1","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:46:58Z","timestamp":1773193618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Healthcare professionals\u2019 perspectives on a population-based lung cancer screening programme in Flanders: a cross-sectional survey study"],"prefix":"10.1186","volume":"26","author":[{"given":"Lauren","family":"Michiels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caro","family":"Verlies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Dooms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Van Hal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Huys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"14255_CR1","unstructured":"World Health Organization. Lung cancer: fact sheet [Internet]. 2023 [cited 2025 Jun 11]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lung-cancer"},{"key":"14255_CR2","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jtho.2021.07.022","volume":"16","author":"S Ocak","year":"2021","unstructured":"Ocak S, Tournoy K, Berghmans T, Demedts I, Durieux R, Janssens A, et al. Lung Cancer in Belgium. J Thorac Oncol. 2021;16:1610\u201321. https:\/\/doi.org\/10.1016\/j.jtho.2021.07.022.","journal-title":"J Thorac Oncol"},{"key":"14255_CR3","unstructured":"Belgian Cancer Registry. Publications [Internet]. [cited 2025 Jun 11]. Available from: http:\/\/kankerregister.org\/Publications"},{"key":"14255_CR4","doi-asserted-by":"publisher","unstructured":"Knight SB, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7. https:\/\/doi.org\/10.1098\/rsob.170070.","DOI":"10.1098\/rsob.170070"},{"key":"14255_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.hoc.2024.03.004","volume":"38","author":"AEB Chang","year":"2024","unstructured":"Chang AEB, Potter AL, Yang CFJ, Sequist LV. Early detection and interception of lung cancer. Hematol Oncol Clin North Am. 2024;38:755\u201370. https:\/\/doi.org\/10.1016\/j.hoc.2024.03.004.","journal-title":"Hematol Oncol Clin North Am"},{"key":"14255_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/nejmoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503\u201313. https:\/\/doi.org\/10.1056\/nejmoa1911793.","journal-title":"N Engl J Med"},{"key":"14255_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/eurpub\/ckv158","volume":"26","author":"A Puggina","year":"2016","unstructured":"Puggina A, Broumas A, Ricciardi W, Boccia S. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review. Eur J Public Health. 2016;26:168\u201375. https:\/\/doi.org\/10.1093\/eurpub\/ckv158.","journal-title":"Eur J Public Health"},{"key":"14255_CR8","unstructured":"Desimpel F, Luyten J, Camberlin C, Jong CP-D, Verleye L, Neyt M, et al. Lung cancer screening in a high-risk population. n.d."},{"key":"14255_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening","year":"2011","unstructured":"Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med. 2011;365:395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873.","journal-title":"N Engl J Med"},{"key":"14255_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/annonc\/mdz117","volume":"30","author":"U Pastorino","year":"2019","unstructured":"Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019;30:1162\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdz117.","journal-title":"Ann Oncol"},{"key":"14255_CR11","unstructured":"Lung Cancer Policy Network. Interactive map of lung cancer screening [Internet]. 2025 [cited 2025 Oct 30]. Available from: https:\/\/www.lungcancerpolicynetwork.com\/interactive-map-of-lung-cancer-screening\/"},{"key":"14255_CR12","doi-asserted-by":"publisher","unstructured":"Poon C, Wilsdon T, Sarwar I, Roediger A, Yuan M. Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption. Front Public Health. 2023;11. https:\/\/doi.org\/10.3389\/fpubh.2023.1264342.","DOI":"10.3389\/fpubh.2023.1264342"},{"key":"14255_CR13","unstructured":"Belgian Cancer Registry. Screening [Internet]. [cited 2025 Jun 11]. Available from: https:\/\/kankerregister.org\/fr\/screening"},{"key":"14255_CR14","unstructured":"ZORALCS. ZORALCS: Pilot study for organized lung cancer screening in Flanders [Internet]. 2025 [cited 2025 Oct 30]. Available from: https:\/\/zoralcs.be\/en\/"},{"key":"14255_CR15","doi-asserted-by":"publisher","unstructured":"Diab Garcia P, Snoeckx A, Van Meerbeeck JP, Van Hal G. A cross-sectional study on the acceptability of implementing a lung cancer screening program in Belgium. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15010278.","DOI":"10.3390\/cancers15010278"},{"key":"14255_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3122\/jabfm.2023.230109R1","volume":"36","author":"SE Golden","year":"2024","unstructured":"Golden SE, Currier JJ, Ramalingam NP, Patzel M, Shannon J, Davis MM, et al. Primary care providers experiences implementing low-dose computed tomography recommendations for lung cancer screening. J Am Board Fam Med. 2024;36:952\u201365. https:\/\/doi.org\/10.3122\/jabfm.2023.230109R1.","journal-title":"J Am Board Fam Med"},{"key":"14255_CR17","doi-asserted-by":"publisher","unstructured":"Olazagasti C, Bernabe C, Seetharamu N. Lung cancer screening guidelines are clear but are they being followed? Lung Cancer Manag. 2020;9. https:\/\/doi.org\/10.2217\/lmt-2020-0015.","DOI":"10.2217\/lmt-2020-0015"},{"key":"14255_CR18","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/j.cllc.2017.05.003","volume":"18","author":"S Rajupet","year":"2017","unstructured":"Rajupet S, Doshi D, Wisnivesky JP, Lin JJ. Attitudes about lung cancer screening: primary care providers versus specialists. Clin Lung Cancer. 2017;18:e417\u201323. https:\/\/doi.org\/10.1016\/j.cllc.2017.05.003.","journal-title":"Clin Lung Cancer"},{"key":"14255_CR19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/jnci\/djac154","volume":"114","author":"AE Sedani","year":"2022","unstructured":"Sedani AE, Davis OC, Clifton SC, Campbell JE, Chou AF. Facilitators and barriers to implementation of lung cancer screening: a framework-driven systematic review. J Natl Cancer Inst. 2022;114:1449\u201367. https:\/\/doi.org\/10.1093\/jnci\/djac154.","journal-title":"J Natl Cancer Inst"},{"key":"14255_CR20","doi-asserted-by":"publisher","unstructured":"Margariti C, Kordowicz M, Selman G, Nair A, Akande Y, Saleem A, et al. Healthcare professionals\u2019 perspectives on lung cancer screening in the UK: a qualitative study. BJGP Open. 2020;4. https:\/\/doi.org\/10.3399\/bjgpopen20X101035.","DOI":"10.3399\/bjgpopen20X101035"},{"key":"14255_CR21","unstructured":"Council of the European Union. Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new approach for a successful cancer screening (2022\/C 476\/01). Official Journal of the European Union. 2022 Dec 9. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32022H1213(01)."},{"key":"14255_CR22","doi-asserted-by":"publisher","unstructured":"Dodd RH, Sharman AR, Marshall HM, Yap ML, Stone E, Rhee J, et al. \u201cWhat do I think about implementing lung cancer screening? It all depends on how.\u201d Acceptability and feasibility of lung cancer screening in Australia: the view of key stakeholders about health system factors. PLoS One. 2023;18. https:\/\/doi.org\/10.1371\/journal.pone.0283939.","DOI":"10.1371\/journal.pone.0283939"},{"key":"14255_CR23","doi-asserted-by":"publisher","unstructured":"Kauczor HU, von Stackelberg O, Nischwitz E, Chorostowska-Wynimko J, Hierath M, Mathonier C, et al. Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium. Insights Imaging. 2024;15. https:\/\/doi.org\/10.1186\/s13244-024-01814-5.","DOI":"10.1186\/s13244-024-01814-5"},{"key":"14255_CR24","unstructured":"World Health Organization. Croatia implements nationwide lung cancer screening programme to address high burden of disease [Internet]. European Observatory on Health Systems and Policies; 2025 [cited 2025 Oct 30]. Available from: https:\/\/eurohealthobservatory.who.int\/monitors\/pace\/case-studies\/pace\/pace-croatia-2025\/croatia-implements-nationwide-lung-cancer-screening-programme-to-address-high-burden-of-disease"},{"key":"14255_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41571-020-00432-6","volume":"18","author":"M Oudkerk","year":"2021","unstructured":"Oudkerk M, Liu SY, Heuvelmans MA, Walter JE, Field JK. Lung cancer LDCT screening and mortality reduction \u2014 evidence, pitfalls and future perspectives. Nat Rev Clin Oncol. 2021;18:135\u201351. https:\/\/doi.org\/10.1038\/s41571-020-00432-6.","journal-title":"Nat Rev Clin Oncol"},{"key":"14255_CR26","doi-asserted-by":"publisher","unstructured":"Rennert L, Zhang L, Lumsden B, Harwood K, Tyler L, Ashby M, et al. Factors influencing lung cancer screening completion following participation in shared decision-making: a retrospective study in a US. academic health system. Cancer Treat Res Commun. 2020;24. https:\/\/doi.org\/10.1016\/j.ctarc.2020.100198.","DOI":"10.1016\/j.ctarc.2020.100198"},{"key":"14255_CR27","doi-asserted-by":"publisher","unstructured":"Carter-Bawa L, Ostroff JS, Hoover K, Studts JL. Effective communication about lung cancer screening without iatrogenic stigma: a brief report case study using the lung cancer stigma communications assessment tool of lungtalk. JTO Clin Res Rep. 2023;4. https:\/\/doi.org\/10.1016\/j.jtocrr.2023.100585.","DOI":"10.1016\/j.jtocrr.2023.100585"},{"key":"14255_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7326\/M22-2216","volume":"176","author":"I Toumazis","year":"2023","unstructured":"Toumazis I, Cao P, de Nijs K, Bastani M, Munshi V, Hemmati M, et al. Risk model\u2013based lung cancer screening a cost-effectiveness analysis. Ann Intern Med. 2023;176:320\u201332. https:\/\/doi.org\/10.7326\/M22-2216.","journal-title":"Ann Intern Med"},{"key":"14255_CR29","doi-asserted-by":"publisher","unstructured":"ten Haaf K, Jeon J, Tammem\u00e4gi MC, Han SS, Kong CY, Plevritis SK, et al. Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study. PLoS Med. 2017;14. https:\/\/doi.org\/10.1371\/journal.pmed.1002277.","DOI":"10.1371\/journal.pmed.1002277"},{"key":"14255_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ijc.33578","volume":"149","author":"K ten Haaf","year":"2021","unstructured":"ten Haaf K, van der Aalst CM, de Koning HJ, Kaaks R, Tammem\u00e4gi MC. Personalising lung cancer screening: an overview of risk-stratification opportunities and challenges. Int J Cancer. 2021;149:250\u201363. https:\/\/doi.org\/10.1002\/ijc.33578.","journal-title":"Int J Cancer"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14255-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14255-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14255-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:01:23Z","timestamp":1776387683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14255-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14255"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14255-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Ethics Committee Research of University Hospitals Leuven (UZ Leuven) and KU Leuven, Belgium (S69748). The committee confirmed that the study did not fall under the scope of the Belgian Law of 7 May 2004 on experiments on the human person, as it involved an anonymous, non-interventional survey among HCPs. Because the survey was fully anonymous and voluntary, written informed consent was not required; completion of the questionnaire was considered to imply consent. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}